ResearcherUniversity of MichiganActive in the last 2 years
Dominik Awad
Matched on ORCID iD 0000-0002-7386-2061; OpenAlex author ID A5059747399. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper
Papers 4
- Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer. Co-author DOI 10.1158/2326-6066.cir-25-1300↗
- Targeting PIKfyve-driven lipid metabolism in pancreatic cancer. Co-author DOI 10.1038/s41586-025-08917-z↗
- Aspartate Transaminases Are Dispensable for Pancreatic Development and Pancreatic Cancer Progression Co-author DOI 10.64898/2025.12.17.694916↗
- An unexpected pathway to polyamines in pancreatic cancer. Co-author DOI 10.1016/j.molcel.2023.05.014↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Costas Andreas Lyssiotis · 4 shared papers, 2023–2026 · strength 0.94
- Paper An unexpected pathway to polyamines in pancreatic cancer. DOI 10.1016/j.molcel.2023.05.014↗
- Paper Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer. DOI 10.1158/2326-6066.cir-25-1300↗
- Paper Aspartate Transaminases Are Dispensable for Pancreatic Development and Pancreatic Cancer Progression DOI 10.64898/2025.12.17.694916↗
- Marina Pasca di Magliano · 3 shared papers, 2025–2026 · strength 0.56
- Paper Targeting CCR1 Remodels the Tumor Microenvironment and Relieves Immunosuppression in Pancreatic Cancer. DOI 10.1158/2326-6066.cir-25-1300↗
- Paper Aspartate Transaminases Are Dispensable for Pancreatic Development and Pancreatic Cancer Progression DOI 10.64898/2025.12.17.694916↗
- Paper Targeting PIKfyve-driven lipid metabolism in pancreatic cancer. DOI 10.1038/s41586-025-08917-z↗
- Timothy L. Frankel · 2 shared papers, 2025–2026 · strength 0.39
- Filip Bednar · 2 shared papers, 2025–2026 · strength 0.39
- Rosa Elena Menjivar · 1 shared paper, 2026 · strength 0.20
- Zeribe C. Nwosu · 1 shared paper, 2026 · strength 0.20
- Emily L. Lasse Opsahl · 1 shared paper, 2026 · strength 0.20
- Eileen S. Carpenter · 1 shared paper, 2026 · strength 0.20
- Padma Kadiyala · 1 shared paper, 2026 · strength 0.20
- Ahmed M. Elhossiny · 1 shared paper, 2026 · strength 0.20
- Wei Yan · 1 shared paper, 2026 · strength 0.20
- Katelyn L. Donahue · 1 shared paper, 2026 · strength 0.20
- Yaqing Zhang · 1 shared paper, 2026 · strength 0.20
- Megan D. Radyk · 1 shared paper, 2025 · strength 0.19
- Samuel Andrew Kerk · 1 shared paper, 2025 · strength 0.19
- Julia Ugras · 1 shared paper, 2025 · strength 0.19
- Jing Hu · 1 shared paper, 2025 · strength 0.17
- Arul M. Chinnaiyan · 1 shared paper, 2025 · strength 0.17
- Jennifer P. Morton · 1 shared paper, 2025 · strength 0.17
- Vaibhav Sahai · 1 shared paper, 2025 · strength 0.17
- Caleb Cheng · 1 shared paper, 2025 · strength 0.17
- Li Zhang · 1 shared paper, 2025 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.